首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nar cancer

缩写:

ISSN:2632-8674

e-ISSN:2632-8674

IF/分区:4.6/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引326条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Debojyoti Chowdhury,Shreyansh Priyadarshi,Sayan Biswas et al. Debojyoti Chowdhury et al.
Cancer stem-like cells (CSCs) play a pivotal role in driving tumor heterogeneity, therapeutic resistance, and disease progression. Despite the power of single-cell RNA sequencing (scRNA-seq) to resolve intratumoral hierarchies, there remain...
Lee J Pribyl,Jennifer E Kay,Joshua J Corrigan et al. Lee J Pribyl et al.
N-Nitrosodimethylamine (NDMA), a probable human carcinogen, induces toxic and mutagenic DNA O 6-methylguanine (O 6MeG) adducts that are repaired by O 6-methylguanine-DNA methyltransferase (MGMT). To elucidate how early-life environmental mu...
Lauryn Buckley-Benbow,Meryem Ozgencil,Alessia Tardocchi et al. Lauryn Buckley-Benbow et al.
The use of PARP inhibitors (PARPi) has profoundly changed the treatment of BRCA1/BRCA2-mutated cancers. Despite this, acquired resistance to PARPi has become a major challenge in the clinic. Hence, a more detailed understanding of the mecha...
Thi Tran,Jiayi Fan,Xiaolan Zhao et al. Thi Tran et al.
The structural maintenance of chromosomes (SMC) 5/6 complex is conserved and essential for mammalian development. SMC5/6 germline variants in cells, model organisms, and patients results in genome instability. However, the consequences of s...
Meifang Qi,Preshita Sanjay Dave,Nicole Francis et al. Meifang Qi et al.
Somatic mutations in protein-coding genes and noncoding regulatory regions are the major drivers of cancer. Only a relatively small number of somatic noncoding mutations that are likely drivers have been described to date, including those i...
Tomoaki Fujii,Yukimi Sakoda,Kazuto Yoshimi et al. Tomoaki Fujii et al.
The CRISPR-Cas9 system has been widely adopted as a genome editing tool due to its high efficiency and versatility, contributing to the development of various therapeutic strategies. However, its clinical application remains limited by safe...
Berenice Cuevas-Estrada,Juan A Ríos-Rodríguez,José A García-Pacheco et al. Berenice Cuevas-Estrada et al.
Testicular germ cell tumors (TGCT) are highly heritable malignancies that display increasing incidence worldwide, with rising mortality rates particularly evident among Hispanic men. However, genomic studies of TGCT have largely focused on ...
Reshma Kalyan Sundaram,Kshitiz Parihar,Stephanie Monson et al. Reshma Kalyan Sundaram et al.
The transcription factor c-MYC (MYC) is deregulated in ~70% of human cancers. Through de novo motif discovery analysis on published MYC ChIP-seq datasets from cancer cell lines, we found cell-type-specific co-enrichment of the TRE motifs (A...
Jennifer R Tall,Robert Te Poele,Alexandra Vasile et al. Jennifer R Tall et al.
Transcription factor heat shock factor 1 (HSF1) orchestrates the cellular stress response, promoting malignant transformation, unchecked proliferation, and stress-resilient survival of tumour cells. We set out to discover potentially drugga...
Ádám Tamás Sánta,Alexandra Gráf,Katalin Vincze-Kontár et al. Ádám Tamás Sánta et al.
Synthetic lethality offers opportunities to identify therapeutic targets for cancer research, facilitating the development of targeted tumour therapy protocols. However, current gene knockout approaches may cause compensatory changes in cel...